| MPS IVA | Mucopolysaccharidosis IVA |
| GALNS | N-acetylgalactosamine-6-sulfate sulfatase |
| GAGs | Glycosaminoglycans |
| KS | Keratan sulfate |
| C6S | Chondroitin-6-sulfate |
| LV | Lentiviral vectors |
| LVGT | Lentiviral gene therapy |
| VSVG | Vesicular stomatitis virus glycoprotein |
| IV | Intravenous |
| IA | Intraarticular |
| ERT | Enzyme replacement therapy |
| AAV | Adeno-associated virus |
| ECM | Extracellular matrix |
| HE | Hematoxylin and eosin |
| VCN | Vector copy number |
| LDL | Low-density lipoprotein |
| KO | Knockout |
| WBCs | White blood cells |
| BMCs | Bone marrow cells |
| LC-MS/MS | Liquid chromatography–tandem mass spectrometry |
| ddPCR | Digital droplet polymerase chain reaction |
| qPCR | Quantitative polymerase chain reaction |
| ALT | Alanine aminotransferase |
| AST | Aspartate aminotransferase |
| ELISA | Enzyme-linked immunosorbent assay |
| WT | Wild-type |
| UT | Untreated |
| IHC | Immunohistochemistry |
| μCT | Micro-computational tomography |